Chao Xia
Chao Xia has a total of 53 co-authors. Here are the top co-authors by number of shared publications:
- Qianjun He
Shanghai Key Laboratory of Hydrogen Science & Center of Hydrogen Science, School of Materials Science and Engineering, Shanghai Jiao Tong University, Shanghai 200240, China
5 shared publications - Huili Li
Engineering Research Center for Nanophotonics & Advanced Instrument, Ministry of Education, School of Physics and Electronic Science, East China Normal University, Shanghai 200241, P. R. China
4 shared publications Guohong Zhou
Key Laboratory of Transparent Optofunctional Inorganic Materials, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, P. R. China
3 shared publicationsDanyu Jiang
Key Laboratory of Transparent Optofunctional Inorganic Materials, Shanghai Institute of Ceramics, Chinese Academy of Sciences, Shanghai 200050, P. R. China
2 shared publications- Jinfeng Xia
Chinese Academy of Sciences
2 shared publications Mengmeng Cao
Engineering Research Center for Nanophotonics and Advanced Instrument, Ministry of Education, School of Physics and Electronic Science, East China Normal University, Shanghai 200241, China
2 shared publications
Latest Publications
- Open Access
- 27 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (9) , eaea3355
Inflamed vessel–anchored release of H 2 across the blood-brain barrier for ischemic stroke neuroprotection
Ischemic stroke followed by reperfusion urgently requires safe and efficient cytoprotective strategies, a need still unmet by current pharmacotherapies. Nanotechnology holds promise for improved drug delivery to the brain, yet the efficacy of nanomaterials crossing the blood-brain barrier (BBB) is quite limited, and long-term intracranial retention of nanomaterials may provoke neurotoxicity. Leveraging the anti-inflammatory, BBB-crossing, and biosafe properties of hydrogen (H 2 ), we develop an inflamed vessel–targeted/anchored H 2 –producing system by modifying ZrSi 2 nanoparticles with a P-selectin–binding peptide (ZSNP), mimicking P-selectin/P-selectin glycoprotein ligand–mediated innate immune recruitment. Rather than relying on nanoparticle penetration into the brain parenchyma, this design enables ZSNP to anchor at the BBB vasculature, where it locally and continuously generates H 2 via hydrolysis. The released H 2 traverses the BBB, exerting cytoprotection through antioxidant and immunomodulatory mechanisms that coordinate multicellular recovery processes. Furthermore, ZSNP promotes microglia-mediated angiogenesis and neurogenesis, guides axonal projections along neovascular trajectories, and facilitates microglia-neuron interaction via the noncanonical Wnt/Ca 2+ pathway. This reconstruction of the neurovascular network supports the reintegration of functional neural circuits, leading to structural and functional recovery that surpasses the effects of edaravone. By enabling sustained H 2 release at the BBB interface without requiring nanoparticle intracranial accumulation, this strategy represents a promising and low-burden neuroprotective approach for ischemic stroke.
- 27 February 2026
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 12 (9) , eaea3355
Open AccessInflamed vessel–anchored release of H 2 across the blood-brain barrier for ischemic stroke neuroprotection
Ischemic stroke followed by reperfusion urgently requires safe and efficient cytoprotective strategies, a need still unmet by current pharmacotherapies. Nanotechnology holds promise for improved drug delivery to the brain, yet the efficacy of nanomaterials crossing the blood-brain barrier (BBB) is quite limited, and long-term intracranial retention of nanomaterials may provoke neurotoxicity. Leveraging the anti-inflammatory, BBB-crossing, and biosafe properties of hydrogen (H 2 ), we develop an inflamed vessel–targeted/anchored H 2 –producing system by modifying ZrSi 2 nanoparticles with a P-selectin–binding peptide (ZSNP), mimicking P-selectin/P-selectin glycoprotein ligand–mediated innate immune recruitment. Rather than relying on nanoparticle penetration into the brain parenchyma, this design enables ZSNP to anchor at the BBB vasculature, where it locally and continuously generates H 2 via hydrolysis. The released H 2 traverses the BBB, exerting cytoprotection through antioxidant and immunomodulatory mechanisms that coordinate multicellular recovery processes. Furthermore, ZSNP promotes microglia-mediated angiogenesis and neurogenesis, guides axonal projections along neovascular trajectories, and facilitates microglia-neuron interaction via the noncanonical Wnt/Ca 2+ pathway. This reconstruction of the neurovascular network supports the reintegration of functional neural circuits, leading to structural and functional recovery that surpasses the effects of edaravone. By enabling sustained H 2 release at the BBB interface without requiring nanoparticle intracranial accumulation, this strategy represents a promising and low-burden neuroprotective approach for ischemic stroke.
- 5 September 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (18) , 19554-19566
Engineering of an Exosome-Based GPIHBP1 mRNA Delivery System for Efficient Therapy of Familial Hypertriglyceridemia
Familial hypertriglyceridemia (FHTG), a severe subtype of primary hypertriglyceridemia caused by mutations in GPIHBP1 and other related genes, is linked to life-threatening cardiovascular complications. Current therapies inadequately address the underlying genetic pathology. Here, we developed a novel exosome-based mRNA delivery platform to restore functional glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) expression, providing a targeted therapeutic strategy for FHTG. Using GPIHBP1-/- mice as disease models, we engineered exosomes (ExoGPIHBP1) encapsulating GPIHBP1 mRNA via an optimized vector. These exosomes exhibited high biostability and preferential liver accumulation after systemic administration, enabling efficient protein translation. Consequently, treatment significantly reduced serum triglyceride (TG) levels, attenuated lipid accumulation, and ameliorated liver steatosis. Our study explores exosome-mediated GPIHBP1 mRNA therapy as a precise, safe, and effective strategy for FHTG, highlighting a considerable translational potential for genetic dyslipidemias. The platform advances RNA-based therapeutics by bridging the gap between gene therapy and clinical applications.
- 5 September 2025
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 68 (18) , 19554-19566
Engineering of an Exosome-Based GPIHBP1 mRNA Delivery System for Efficient Therapy of Familial Hypertriglyceridemia
Familial hypertriglyceridemia (FHTG), a severe subtype of primary hypertriglyceridemia caused by mutations in GPIHBP1 and other related genes, is linked to life-threatening cardiovascular complications. Current therapies inadequately address the underlying genetic pathology. Here, we developed a novel exosome-based mRNA delivery platform to restore functional glycosylphosphatidylinositol-anchored high-density lipoprotein-binding protein 1 (GPIHBP1) expression, providing a targeted therapeutic strategy for FHTG. Using GPIHBP1-/- mice as disease models, we engineered exosomes (ExoGPIHBP1) encapsulating GPIHBP1 mRNA via an optimized vector. These exosomes exhibited high biostability and preferential liver accumulation after systemic administration, enabling efficient protein translation. Consequently, treatment significantly reduced serum triglyceride (TG) levels, attenuated lipid accumulation, and ameliorated liver steatosis. Our study explores exosome-mediated GPIHBP1 mRNA therapy as a precise, safe, and effective strategy for FHTG, highlighting a considerable translational potential for genetic dyslipidemias. The platform advances RNA-based therapeutics by bridging the gap between gene therapy and clinical applications.
- 17 July 2025
- Published by American Chemical Society (ACS) in Accounts of Materials Research
- Vol. 6 (8) , 1020-1032
Hydrogen Medicine Materials
- 17 July 2025
- Published by American Chemical Society (ACS) in Accounts of Materials Research
- Vol. 6 (8) , 1020-1032
Hydrogen Medicine Materials
- 28 April 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (18) , 15519-15533
Hydrogen Incorporation Selectively Modulates the Catalytic Performance of Pd Nanozymes for Cascade-Catalytic Tumor Therapy
Pd-based nanozymes have emerged as promising alternatives to natural enzymes, but their application is still constrained due to suboptimal activity and poor specificity. As efficient hydrogen storage nanomaterials, the specific implications of implanted hydrogen on the enzyme-mimicking activity of Pd-based nanomaterials remain largely uninvestigated. In this study, we discovered that hydrogenation process significantly enhances the enzyme-like activity of Pd-based nanomaterials, although reaction specificity varies in dependence on the synthetic route of Pd hydrides. Pd/H2 nanocubes (NCs), which are synthesized by directly injecting hydrogen gas into a solution containing Pd NCs, exhibit a selective enhancement in antioxidative activity against cytotoxic hydrogen peroxide (H2O2), superoxide anion (O2•-), and hydroxyl radical (•OH) due to the sustained release of bioreductive hydrogen. In contrast, stable Pd hydride NCs, which are prepared through the in situ catalytic decomposition of alternative sources of hydrogen atoms, exhibit a remarkable enhancement in exclusive H2O2 activation pathways, specifically exhibiting peroxidase (POD)-like and catalase (CAT)-like activities. Multiple spectroscopic characterizations and density functional theory (DFT) calculations confirmed that this high catalytic activity and specificity of PdH NCs arise from lattice tensile strain and electronic structure change. Based on these findings, a PdH/glucose oxidase (GOx) nanocomplex was developed for cascade catalysis in tumor therapy. This work not only reveals that hydride formation can influence both the activity and selectivity of Pd nanozymes but also provides a viable strategy for the precise regulation of specific enzyme-like activity in hydrogen-loading nanozymes.
- 28 April 2025
- Published by American Chemical Society (ACS) in Journal of the American Chemical Society
- Vol. 147 (18) , 15519-15533
Hydrogen Incorporation Selectively Modulates the Catalytic Performance of Pd Nanozymes for Cascade-Catalytic Tumor Therapy
Pd-based nanozymes have emerged as promising alternatives to natural enzymes, but their application is still constrained due to suboptimal activity and poor specificity. As efficient hydrogen storage nanomaterials, the specific implications of implanted hydrogen on the enzyme-mimicking activity of Pd-based nanomaterials remain largely uninvestigated. In this study, we discovered that hydrogenation process significantly enhances the enzyme-like activity of Pd-based nanomaterials, although reaction specificity varies in dependence on the synthetic route of Pd hydrides. Pd/H2 nanocubes (NCs), which are synthesized by directly injecting hydrogen gas into a solution containing Pd NCs, exhibit a selective enhancement in antioxidative activity against cytotoxic hydrogen peroxide (H2O2), superoxide anion (O2•-), and hydroxyl radical (•OH) due to the sustained release of bioreductive hydrogen. In contrast, stable Pd hydride NCs, which are prepared through the in situ catalytic decomposition of alternative sources of hydrogen atoms, exhibit a remarkable enhancement in exclusive H2O2 activation pathways, specifically exhibiting peroxidase (POD)-like and catalase (CAT)-like activities. Multiple spectroscopic characterizations and density functional theory (DFT) calculations confirmed that this high catalytic activity and specificity of PdH NCs arise from lattice tensile strain and electronic structure change. Based on these findings, a PdH/glucose oxidase (GOx) nanocomplex was developed for cascade catalysis in tumor therapy. This work not only reveals that hydride formation can influence both the activity and selectivity of Pd nanozymes but also provides a viable strategy for the precise regulation of specific enzyme-like activity in hydrogen-loading nanozymes.
- 19 January 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 10 (5) , 1690-1697
Bifunctional color-tuning luminescent Ln@Zr-MOFs for white LEDs and sensitive, ultrafast detection of nitrobenzene in aqueous media
Rapid and quantitative detection of nitrobenzene (NB) in wastewater is of great significance to protect the natural environment and human health. In this work, bifunctional Ln@Zr-MOFs based on UiO-66 were successfully fabricated by partially replacing terephthalic acid (H2BDC) ligands with m-phthalic acid (m-H2BDC) ligands and post-synthetic modification (PSM) with Ln3+ (Ln3+ = Eu3+, Tb3+). The “antenna effect” of the m-H2BDC ligands makes Ln@Zr-MOFs exhibit the characteristic emissions of Ln3+. By adjusting the amount and type of Ln3+, controllable color-tuning emissions can be easily realized, which endows them with a great application prospect for white LEDs. On the other hand, Eu10@Zr-MOFs can serve as a turn-off fluorescent switch of NB because the red emission from Eu3+ can be easily quenched by NB through a photoinduced electron transfer (PET) process between NB and its ligands, and as a result, NB is successfully recognized. Particularly, Eu10@Zr-MOFs as a fluorescent probe have shown many appealing properties, such as high sensitivity (limit of detection is 1.04 μM, limit of quantification is 3.48 μM, and Ksv = 24459.71 M−1), quick response (less than 60 s), a broad response window (0–180 μM), excellent selectivity, and strong anti-interference ability. The real detection results of NB concentration in natural water samples have demonstrated that the reported Eu10@Zr-MOFs are a potential fluorescent material that can precisely and sensitively perform fluorescence sensing of NB.
- 19 January 2022
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 10 (5) , 1690-1697
Bifunctional color-tuning luminescent Ln@Zr-MOFs for white LEDs and sensitive, ultrafast detection of nitrobenzene in aqueous media
Rapid and quantitative detection of nitrobenzene (NB) in wastewater is of great significance to protect the natural environment and human health. In this work, bifunctional Ln@Zr-MOFs based on UiO-66 were successfully fabricated by partially replacing terephthalic acid (H2BDC) ligands with m-phthalic acid (m-H2BDC) ligands and post-synthetic modification (PSM) with Ln3+ (Ln3+ = Eu3+, Tb3+). The “antenna effect” of the m-H2BDC ligands makes Ln@Zr-MOFs exhibit the characteristic emissions of Ln3+. By adjusting the amount and type of Ln3+, controllable color-tuning emissions can be easily realized, which endows them with a great application prospect for white LEDs. On the other hand, Eu10@Zr-MOFs can serve as a turn-off fluorescent switch of NB because the red emission from Eu3+ can be easily quenched by NB through a photoinduced electron transfer (PET) process between NB and its ligands, and as a result, NB is successfully recognized. Particularly, Eu10@Zr-MOFs as a fluorescent probe have shown many appealing properties, such as high sensitivity (limit of detection is 1.04 μM, limit of quantification is 3.48 μM, and Ksv = 24459.71 M−1), quick response (less than 60 s), a broad response window (0–180 μM), excellent selectivity, and strong anti-interference ability. The real detection results of NB concentration in natural water samples have demonstrated that the reported Eu10@Zr-MOFs are a potential fluorescent material that can precisely and sensitively perform fluorescence sensing of NB.
- 6 August 2021
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 14 (1) , e1744
Therapeutic gas delivery strategies
Gas molecules with pharmaceutical effects offer emerging solutions to diseases. In addition to traditional medical gases including O2 and NO, more gases such as H2, H2S, SO2, and CO have recently been discovered to play important roles in various diseases. Though some issues need to be addressed before clinical application, the increasing attention to gas therapy clearly indicates the potentials of these gases for disease treatment. The most important and difficult part of developing gas therapy systems is to transport gas molecules of high diffusibility and penetrability to interesting targets. Given the particular importance of gas molecule delivery for gas therapy, distinguished strategies have been explored to improve gas delivery efficiency and controllable gas release. Here, we summarize the strategies of therapeutic gas delivery for gas therapy, including direct gas molecule delivery by chemical and physical absorption, inorganic/organic/hybrid gas prodrugs, and natural/artificial/hybrid catalyst delivery for gas generation. The advantages and shortcomings of these gas delivery strategies are analyzed. On this basis, intelligent gas delivery strategies and catalysts use in future gas therapy are discussed.This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
- 6 August 2021
- Published by Wiley in WIREs Nanomedicine and Nanobiotechnology
- Vol. 14 (1) , e1744
Therapeutic gas delivery strategies
Gas molecules with pharmaceutical effects offer emerging solutions to diseases. In addition to traditional medical gases including O2 and NO, more gases such as H2, H2S, SO2, and CO have recently been discovered to play important roles in various diseases. Though some issues need to be addressed before clinical application, the increasing attention to gas therapy clearly indicates the potentials of these gases for disease treatment. The most important and difficult part of developing gas therapy systems is to transport gas molecules of high diffusibility and penetrability to interesting targets. Given the particular importance of gas molecule delivery for gas therapy, distinguished strategies have been explored to improve gas delivery efficiency and controllable gas release. Here, we summarize the strategies of therapeutic gas delivery for gas therapy, including direct gas molecule delivery by chemical and physical absorption, inorganic/organic/hybrid gas prodrugs, and natural/artificial/hybrid catalyst delivery for gas generation. The advantages and shortcomings of these gas delivery strategies are analyzed. On this basis, intelligent gas delivery strategies and catalysts use in future gas therapy are discussed.This article is categorized under: Therapeutic Approaches and Drug Discovery > Emerging Technologies Therapeutic Approaches and Drug Discovery > Nanomedicine for Oncologic Disease
- 16 March 2020
- Published by Wiley in Journal of the American Ceramic Society
- Vol. 103 (8) , 4507-4516
Preparation of tunable full‐color emission carbon dots and their optical applications in ions detection and bio‐imaging
In this work, we synthesized a series of novel carbon dots (CDs) by using phenylenediamines (three isomers: o‐phenylenediamine, m‐phenylenediamine, and p‐phenylenediamine) as starting materials via facile solvothermal approach. As‐prepared CDs could emit bright blue, green, yellow, orange, and red light with relatively high PLQY, individually. Optical properties could be controlled by simply varying reaction parameters. The luminescent mechanism was investigated and analyzed in detail. Finally, the blue‐emitting CDs and green‐emitting CDs showed many appealing properties, such as high sensitivity (limit of detection = 4.52 and 3.50 nmol/L), quick response (6+ and Al 3+ cations, respectively. Thus, they have potential to be developed as the corresponding optical probes. While as‐prepared orange‐emitting CDs could be applied as a bio‐imaging reagent due to its long‐wavelength emission, relatively high PLQY, low toxicity, excellent water solubility, and good biocompatibility.
- 16 March 2020
- Published by Wiley in Journal of the American Ceramic Society
- Vol. 103 (8) , 4507-4516
Preparation of tunable full‐color emission carbon dots and their optical applications in ions detection and bio‐imaging
In this work, we synthesized a series of novel carbon dots (CDs) by using phenylenediamines (three isomers: o‐phenylenediamine, m‐phenylenediamine, and p‐phenylenediamine) as starting materials via facile solvothermal approach. As‐prepared CDs could emit bright blue, green, yellow, orange, and red light with relatively high PLQY, individually. Optical properties could be controlled by simply varying reaction parameters. The luminescent mechanism was investigated and analyzed in detail. Finally, the blue‐emitting CDs and green‐emitting CDs showed many appealing properties, such as high sensitivity (limit of detection = 4.52 and 3.50 nmol/L), quick response (6+ and Al 3+ cations, respectively. Thus, they have potential to be developed as the corresponding optical probes. While as‐prepared orange‐emitting CDs could be applied as a bio‐imaging reagent due to its long‐wavelength emission, relatively high PLQY, low toxicity, excellent water solubility, and good biocompatibility.
- 30 May 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 7 (28) , 8569-8574
A new CaF2-YAG:Ce composite phosphor ceramic for high-power and high-color-rendering WLEDs
A new CaF2-YAG:Ce phosphor ceramic was fabricated at 700 °C, which shows excellent luminescence performance, and thus it is suitable for use in high-power WLEDs.
- 30 May 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 7 (28) , 8569-8574
A new CaF2-YAG:Ce composite phosphor ceramic for high-power and high-color-rendering WLEDs
A new CaF2-YAG:Ce phosphor ceramic was fabricated at 700 °C, which shows excellent luminescence performance, and thus it is suitable for use in high-power WLEDs.
- 28 January 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 7 (9) , 2563-2569
An ultrafast responsive and sensitive ratiometric fluorescent pH nanoprobe based on label-free dual-emission carbon dots
A ratiometric and self-calibrating fluorescent pH nanoprobe based on label-free DECDs.
- 28 January 2019
- Published by Royal Society of Chemistry (RSC) in Journal of Materials Chemistry C
- Vol. 7 (9) , 2563-2569
An ultrafast responsive and sensitive ratiometric fluorescent pH nanoprobe based on label-free dual-emission carbon dots
A ratiometric and self-calibrating fluorescent pH nanoprobe based on label-free DECDs.
- 21 October 2015
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 40 (1) , 144-150
Aggregation-induced emission enhancement and living cell imaging of novel diarylanthracene conjugated dyes
In this work, two novel diarylanthracene conjugated dyes, CzAn and BCzAn, which contain carbazolyl substituted triarylamine groups, were synthesized by the Ullmann reaction and characterized by 1H NMR, 13C NMR, and HRMS-MALDI-TOF. Both of the diarylanthracene conjugated dyes CzAn and BCzAn demonstrated aggregation-induced emission enhancement (AIEE) properties. CzAn and BCzAn emitted brightly in solid states with maximum emission wavelengths of 576 and 601 nm. BCzAn emitted weakly in THF solutions with a fluorescence quantum yield of 8%, became a strong emitter in the aggregate states with the fluorescence peak intensity increased in THF–water mixtures and DMF–glycerol mixtures rather than in pure solvents. Nanoparticles (Nps) were prepared from CzAn and BCzAn by a hydrophobic interaction with bovine serum albumin (BSA). The diameters of the AIEE dye based BSA nanoparticles were characterized by transmission electron microscopy (TEM) and their photophysical properties were also measured. These BSA nanoparticles showed high water dispersibility, stable uniform morphology (100–200 nm), strong fluorescence, low cytotoxicity and excellent biocompatibility, making them good optical materials for living HeLa cell imaging.
- 21 October 2015
- Published by Royal Society of Chemistry (RSC) in New Journal of Chemistry
- Vol. 40 (1) , 144-150
Aggregation-induced emission enhancement and living cell imaging of novel diarylanthracene conjugated dyes
In this work, two novel diarylanthracene conjugated dyes, CzAn and BCzAn, which contain carbazolyl substituted triarylamine groups, were synthesized by the Ullmann reaction and characterized by 1H NMR, 13C NMR, and HRMS-MALDI-TOF. Both of the diarylanthracene conjugated dyes CzAn and BCzAn demonstrated aggregation-induced emission enhancement (AIEE) properties. CzAn and BCzAn emitted brightly in solid states with maximum emission wavelengths of 576 and 601 nm. BCzAn emitted weakly in THF solutions with a fluorescence quantum yield of 8%, became a strong emitter in the aggregate states with the fluorescence peak intensity increased in THF–water mixtures and DMF–glycerol mixtures rather than in pure solvents. Nanoparticles (Nps) were prepared from CzAn and BCzAn by a hydrophobic interaction with bovine serum albumin (BSA). The diameters of the AIEE dye based BSA nanoparticles were characterized by transmission electron microscopy (TEM) and their photophysical properties were also measured. These BSA nanoparticles showed high water dispersibility, stable uniform morphology (100–200 nm), strong fluorescence, low cytotoxicity and excellent biocompatibility, making them good optical materials for living HeLa cell imaging.